Examkin

Question

Difficulty: Very hardHigh Risk Behaviors

A nurse is providing education to a pregnant client at 16 weeks gestation who has a history of intravenous heroin use. The client is currently stable on prescribed buprenorphine maintenance therapy. The client expresses intense anxiety, stating, 'I want to stop taking the buprenorphine completely because I read online that it will cause my baby to have severe withdrawals after birth.' Which of the following is the most appropriate response by the nurse?

  1. A
    We should discuss a gradual tapering plan with your healthcare provider so that you are completely free of the medication before delivery.
  2. B
    If you abruptly stop the medication, we will need to closely monitor you for early signs of withdrawal, such as profound respiratory depression and pinpoint pupils.
  3. Continuing your prescribed medication is the safest option, as it prevents maternal relapse and fetal distress, which pose a much greater risk than treatable newborn withdrawal.Answer
  4. D
    Do not worry; because buprenorphine is a specifically formulated partial agonist, it will not cross the placenta or affect your baby.

Answer

The most appropriate response is the one that advises continuing the prescribed medication, emphasizing that preventing maternal relapse and fetal distress is a higher priority than avoiding newborn withdrawal.
The correct answer accurately reflects the standard of care and harm reduction principles for pregnant clients exhibiting high-risk behaviors related to opioid use disorder. Medication-assisted treatment (MAT) with buprenorphine or methadone is strongly recommended throughout pregnancy. The severe risks associated with stopping the medication—specifically maternal relapse, fatal overdose, and withdrawal-induced intrauterine fetal demise—far outweigh the risk of Neonatal Abstinence Syndrome (NAS). NAS is an expected, transient, and medically treatable condition in the newborn, whereas relapse can be fatal.

Step-by-Step Solution

1
Analyze the client's statement and identify the underlying concern.
The client is experiencing severe anxiety about Neonatal Abstinence Syndrome (NAS) and is considering abruptly stopping her buprenorphine, which is a critical harm reduction medication.
Identifying the client's knowledge deficit and emotional state is required to provide accurate, therapeutic education.
2
Evaluate the physiological risks associated with the client's proposed plan of action.
Abrupt cessation or even gradual tapering of opioid agonist therapy during pregnancy significantly increases the risk of maternal relapse, overdose, and acute fetal distress or demise.
Understanding maternal-fetal physiology guides the prioritization of harm reduction over a completely drug-free state.
3
Select the response that promotes the highest level of safety while addressing the client's concern therapeutically.
The response that advocates for continuing the medication while accurately acknowledging that newborn withdrawal is a treatable condition is the most appropriate.
This applies evidence-based harm reduction principles and prioritizes life-threatening risks over treatable neonatal complications.

Key Concept

Harm reduction principles and prioritization of medication-assisted treatment (MAT) for opioid use disorder during pregnancy.
Rate this question

Topics

High Risk Behaviors

More questions from this topic